Fulgent Genetics Stock Price on November 13, 2024
| FLGT Stock | USD 16.95 0.33 1.91% |
Below is the normalized historical share price chart for Fulgent Genetics extending back to September 29, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Fulgent Genetics stands at 16.95, as last reported on the 22nd of November, with the highest price reaching 17.71 and the lowest price hitting 16.92 during the day.
If you're considering investing in Fulgent Stock, it is important to understand the factors that can impact its price. Fulgent Genetics secures Sharpe Ratio (or Efficiency) of -0.18, which denotes the company had a -0.18% return per unit of risk over the last 3 months. Fulgent Genetics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Fulgent Genetics' Standard Deviation of 2.59, variance of 6.72, and Mean Deviation of 1.99 to check the risk estimate we provide.
At this time, Fulgent Genetics' Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 1.3 B in 2024, whereas Common Stock Total Equity is likely to drop 2,565 in 2024. . At this time, Fulgent Genetics' Price Earnings To Growth Ratio is comparatively stable compared to the past year. Price To Operating Cash Flows Ratio is likely to gain to 33.48 in 2024, whereas Price Book Value Ratio is likely to drop 0.72 in 2024. Fulgent Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date | 200 Day MA 21.6866 | 50 Day MA 20.5028 | Beta 1.508 |
Fulgent |
Sharpe Ratio = -0.1803
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | FLGT |
Estimated Market Risk
| 2.6 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.47 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Fulgent Genetics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Fulgent Genetics by adding Fulgent Genetics to a well-diversified portfolio.
Price Book 0.4643 | Enterprise Value Ebitda (4.34) | Price Sales 1.9029 | Shares Float 20.4 M | Wall Street Target Price 27.6667 |
Related Headline
Myriad Genetics Headline on 13th of November 2024
Did Myriad Genetics, Inc. Mislead Investors Shareholder Righ... by accesswire.com
NEW YORK, NY ACCESSWIRE November 13, 2024 Levi Korsinsky notifies investors that it has commenced an investigation of Myriad Genetics, Inc. concerning p
Fulgent Genetics Valuation on November 13, 2024
It is possible to determine the worth of Fulgent Genetics on a given historical date. On November 13, 2024 Fulgent was worth 19.14 at the beginning of the trading date compared to the closed value of 18.42. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Fulgent Genetics stock. Still, in general, we apply an absolute valuation method to find Fulgent Genetics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fulgent Genetics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Fulgent Genetics' related companies.
| Open | High | Low | Close | Volume | |
| 19.89 | 20.10 | 19.11 | 19.16 | 275,204 | |
11/13/2024 | 19.14 | 19.56 | 18.38 | 18.42 | 334,525 |
| 18.42 | 18.60 | 17.65 | 17.79 | 294,620 |
| Backtest Fulgent Genetics | | | Fulgent Genetics History | | | Fulgent Genetics Valuation | Previous | Next |
Fulgent Genetics Trading Date Momentum on November 13, 2024
| On November 14 2024 Fulgent Genetics was traded for 17.79 at the closing time. The top price for the day was 18.60 and the lowest listed price was 17.65 . The trading volume for the day was 294.6 K. The trading history from November 14, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.42% . The overall trading delta against the current closing price is 6.03% . |
Fulgent Genetics Fundamentals Correlations and Trends
By evaluating Fulgent Genetics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Fulgent Genetics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Fulgent financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Fulgent Genetics Stock history
Fulgent Genetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Fulgent is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Fulgent Genetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Fulgent Genetics stock prices may prove useful in developing a viable investing in Fulgent Genetics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 29.8 M | 23.5 M | |
| Net Income Applicable To Common Shares | 164.9 M | 101.5 M |
Fulgent Genetics Quarterly Net Working Capital |
|
Fulgent Genetics Stock Technical Analysis
Fulgent Genetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Fulgent Genetics Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Fulgent Genetics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Fulgent Genetics November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Fulgent Genetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fulgent Genetics shares will generate the highest return on investment. By undertsting and applying Fulgent Genetics stock market strength indicators, traders can identify Fulgent Genetics entry and exit signals to maximize returns
Fulgent Genetics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Fulgent Genetics' price direction in advance. Along with the technical and fundamental analysis of Fulgent Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Fulgent to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (0.73) | |||
| Treynor Ratio | (0.54) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.